Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034916.xml
Download PDF
Nervenheilkunde 2014; 33(10): 693-697
DOI: 10.1055/s-0038-1627732
DOI: 10.1055/s-0038-1627732
Update
Psychotherapie bei schizophrenen Erkrankungen
Eine ÜbersichtPsychotherapy for people with schizophreniaan overviewFurther Information
Publication History
eingegangen am:
30 April 2014
angenommen am:
17 July 2014
Publication Date:
24 January 2018 (online)
Zusammenfassung
Die Schizophrenie gehört zu den Erkrankungen, in denen die meisten Lebensjahre in Behinderung verbracht werden. Betrachtet man die letzten 30 Jahre intensiver Psychotherapie-Wirksamkeitsforschung, wird deutlich, dass neben der Pharmakologie, psychotherapeutische Interventionen bei der Behandlung psychotischer Erkrankungen große Erfolge erzielen. Durch evidenzbasierte Psychotherapie kann der Symptomverlauf, die Rezidivprophylaxe und die Rehospitalisierungsrate deutlich verbessert werden. Das Leid der Betroffenen und deren Angehörigen kann minimiert und die gesellschaftlichen Kosten reduziert werden. Die Aufnahme des abgeschwächten Psychosesyndroms in die DSM V gibt Hoffnung auf eine Entwicklung, die eine Grundlage bildet, um in Deutschland spezialisierte Hilfe für junge Menschen mit erhöhtem Psychoserisiko zu etablieren.
Summary
Worldwide schizophrenia belongs to the group of illnesses in which (by comparison) most years of a patient life are spent in disablement. Looking back on 30 years of research of psychotherapy it becomes evident that alongside clinical pharmacology, psychotherapeutic interventions determine the effectiveness of successful treatments. Using evidence based psychotherapy the progress of symptoms, the relapse prophylaxis and the rate of re-hospitalization can be significantly improved. The distress of the affected and their relatives can be minimized and costs to society reduced. The entry of the attenuated psychosis syndrome into the DSM V is an important step and gives reason to hope for a development in which specialized help for young people with high psychosis risk factors will be available in Germany too.
-
Literatur
- 1 Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349: 1436-1442.
- 2 Mueser KT, Salyers MP, Mueser PR. A prospective analysis of work in schizophrenia. Schizophrenia Bulletin 2001; 27 (02) 281-296.
- 3 Clouth J. Costs of early retirement – The case of schizophrenia. Psychiatrische Praxis 2004; 31 (02) 238-45.
- 4 Robinson D. et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 1999; 56 (03) 241.
- 5 Lieberman JA. et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine 2005; 353 (12) 1209-1223.
- 6 Keefe R. Cognitive deficits in patients with schizophrenia: effects and treatment. The Journal of Clinical Psychiatry 2006; 68: 8-13.
- 7 Rummel-Kluge C, Kluge M, Kissling W. Frequency and relevance of psychoeducation in psychiatric diagnoses: results of two surveys five years apart in German-speaking European countries. BMC psychiatry 2013; 13: 170.
- 8 Bäuml J, Pitschel-Walz G. Psychoedukation bei schizophrenen Erkrankungen: Konsensuspapier der Arbeitsgruppe “Psychoedukation bei schizophrenen Erkrankungen”. 2. Aufl. Stuttgart: Schattauer 2007
- 9 Xia J, Merinder LB, Belgamwar MR. Psychoeducation for schizophrenia. Cochrane Database Database Systematic Reviews 2011; 15 (06) CD002831.
- 10 Lincoln TM, Wilhelm K, Nestoriuc Y. Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: a meta-analysis. Schizophrenia Research 2007; 96 (1–3): 232-245.
- 11 Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophrenia Bulletin 2008; 34 (03) 523-537.
- 12 Morrison AP. et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet 2014; 383 (9926): 1395-1403.
- 13 Turner DT, van der Gaag M, Karyotaki E, Cuipers P. Psychological Interventions for Psychosis: A Meta-Analysis of Comparative Outcome Studies. American Journal of Psychiatry. 2014 doi: 10.1176/appi.ajp.2013.13081159
- 14 Birchwood M, Michail M, Meaden A. Cognitive behavior therapy to prevent harmful compliance with command hallucinations (COMMAND): a randomised controlled trial. Lancet 2014; 01 (01) 23-33.
- 15 Lynch D, Laws KR, McKenna PJ. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of wellcontrolled trials. Psychological Medicine 2010; 40 (01) 9-24.
- 16 Buchkremer G. et al. Psychoeducational psychotherapy for schizophrenic patients and their key relatives or care-givers: results of a 2-year followup. Acta Psychiatrica Scandinavica 1997; 96 (06) 483-91.
- 17 Gumley A. et al. Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapy. Psychological Medicine 2003; 33 (03) 419-31.
- 18 Herz M. et al. A program for relapse prevention in schizophrenia: a controlled study. Archives of General Psychiatry 2000; 57 (03) 277-283.
- 19 Hogarty GE. et al. Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry 1997; 154 (11) 1504-1513.
- 20 Klingberg S. et al. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophrenia Bulletin 2011; 37 (02) 98-110.
- 21 Kurtz MM, Mueser KT. A meta-analysis of controlled research on social skills training for schizophrenia. Journal of Consulting and Clinical Psychology 2008; 76 (03) 491-504.
- 22 McGurk SR. et al. A meta-analysis of cognitive remediation in schizophrenia. American Journal of Psychiatry 2007; 164 (12) 1791-1802.
- 23 Hogarty GE. et al. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior. Archives of General Psychiatry 2004; 61 (09) 866-876.
- 24 Aghotor J. et al. Metacognitive training for patients with schizophrenia (MCT): feasibility and preliminary evidence for its efficacy. Journal of Behavior Therapy and Experimental Psychiatry 2010; 41 (03) 207-211.
- 25 Jungbauer J, Wittmund B, Angermeyer MC. Der behandelnde Arzt aus Sicht der Angehörigen: Bewältigungsressource oder zusätzliche Belastung?. Psychiatrische Praxis 2002; 29 (06) 279-284.
- 26 Hornung WP. et al. Long-term effects of a psychoeducational psychotherapeutic intervention for schizophrenic outpatients and their key-persons – results of a five-year follow-up. European Archives of Psychiatry and Clinical Neuroscience 1999; 249 (03) 162-167.
- 27 Bäuml J, Kissling W, Pitschel-Walz G. Psychoedukative Gruppen für schizophrene Patienten: Einfluss auf Wissensstand und Compliance. Ergebnisse der Münchner PIP-Studie. Nervenheilkunde 1996; 15 (03) 145-150.
- 28 Pitschel-Walz G. et al. Psychoeducation and compliance in the treatment of schizophrenia: results of the Munich Psychosis Information Project Study. Journal of Clinical Psychiatry 2006; 67 (03) 443-452.
- 29 Pilling S. et al. Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychological Medicine 2002; 32: 763-782.
- 30 Pitschel-Walz G. et al. The Effect of Family Interventions on Relapse and Rehospitalization in Schizophrenia – A Meta-analysis. Schizophrenia Bulletin 2001; 27 (01) 73-92.
- 31 Pharoah F, Mari J, Rathbone J. Wong Family intervention for schizophrenia. Cochrane Database Systematic Reviews 2010; (12) CD000088.
- 32 Lempa G, Montag C, von Haebler D. Auf dem Weg zu einem Manual der psychodynamischen Psychosentherapie. Psychotherapeut 2013; 04: 327-38.
- 33 Preti A, Cella M. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophrenia Research 2010; 123: 30-36.
- 34 Häfner H. et al. Onset and early course of schizophrenia. In: Häfner H, Gattaz WF. Search for the Causes of Schizophrenia. Vol. 3. New York: Springer; 1995: 43-66.
- 35 Fusar-Poli P. et al. Predicting Psychosis: Metaanalysis of Transition Outcomes in Individuals at High Clinical Risk. Archives of General Psychiatry 2012; 69 (03) 220-229.
- 36 Fusar-Poli P, Berger G. Eicosapentaenoic acid interventions in schizophrenia: a meta-analysis of randomized, lacebo-controlled studies. Journal of Clinical Psychopharmacology 2012; 32 (02) 179-85.
- 37 van der Gaag M. et al. Preventing a first episode of psychosis: Meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophrenia Research 2013; 149: 56-62.
- 38 McGlashan TH, Miller TJ, Woods SW. Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophrenia Bulletin 2001; 27 (04) 563-70.
- 39 McGorry PD, Yung AR, Phillips LJ. The “close-in” or ultra high-risk model; a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophrenia Bulletin 2003; 29 (04) 771-790.
- 40 Bird V. et al. Early intervention services, cognitivebehavioural therapy and family intervention in early psychosis: systematic review. British Journal of Psychiatry 2010; 197 (05) 350-356.
- 41 Marshall M, Rathbone J. Cochrane Database Systematic Reviews. 2011; 06: CD004718.
- 42 National Institute for Health and Clinical Excellence (NICE). Schizophrenia – core interventions in the treatment and management of schizophrenia in primary and secondary care. The British Psychological Society and The Royal College of Psychiatrists. 2009
- 43 Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB. Schizophrenia Patient Outcomes Research Team (PORT). The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophrenia Bulletin 2010; 36: 94-103.
- 44 DGPPN. S3-Praxisleitlinien in Psychiatrie und Psychotherapie. Band 1: Behandlungsleitlinie Schizophrenie. Steinkopff: Darmstadt 2006